<DOC>
	<DOCNO>NCT02048917</DOCNO>
	<brief_summary>The purpose study find optimal smoking cessation strategy patient undergo therapy lung head neck cancer select cancer center Kentucky deliver high quality smoke cessation enrol patient . This study also examine feasibility routinely implement array smoke cessation strategy patient population .</brief_summary>
	<brief_title>Optimization Smoking Cessation Strategies Concurrent With Treatment Tobacco Related Malignancies</brief_title>
	<detailed_description>Subjects enrol study place one twelve treatment arm . Subjects twelve treatment regimen receive either varenicline bupropion long-acting nicotine replacement therapy , without use supplemental nicotine replacement therapy , combination either standard care smoke cessation counsel high intensity/motivational smoking cessation counseling .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Patients must â‰¥ 18 year age . Patient newly diagnose recurrent , histologic diagnosis follow tobacco related malignancy : 1 . Lung Bronchus cancer Head &amp; Neck , cancer ( site ) . 2 . Esophagus , Stomach , Pancreas , Kidney , Urinary Bladder , Colon , Rectum , Cervix , Vulvar , Vaginal 3 . Carcinoma situ undergoing definitive surgical resection treatment ( ex : radiation larynx , gynecologic tract hysterectomy , vulvectomy except gynecologic patient undergo ablative local excisional therapy [ laser ablation , cervical conization , LEEP ] . Having smoke least 1 cigarette within 4 week study enrollment . Having least 10pack year history cigarette smoking . Having smoke least one cigarette within 1 month cancer diagnosis . Life expectancy great 1 year . Patient AUDIT score &lt; 10 . Therapy plan curative intent . Patients must ability understand willingness provide sign write informed consent document . Known allergy attribute bupropion , varenicline , transdermal lozenge nicotine . History suicide attempt preparation attempt within past 10 year . CSRSS Baseline/Screening : Patient response `` Yes '' question except question 1 . Hospitalized psychiatric illness within past two year . History Bipolar disorder . Currently take Bupropion depression . Patient take monoamine oxidase inhibitor ( MAOI ) past two week . History eat disorder anorexia bulimia . Active widespread skin disorder psoriasis , chronic urticarial dermatitis History epilepsy seizure disorder . Active severe kidney liver disease . Women must pregnant lactating . Women reproductivepotential must negative serum urine pregnancy test within 7 day prior study enrollment agree use method contraception 30 day follow last cessation drug dose . Patients within three month myocardial infarction . Patients unstable angina serious arrhythmia . Patients psychiatric disability judge investigator clinically significant preclude inform consent compliance drug intake . Patient take varenicline bupropion within one month study enrollment . Participation investigational drug study within 4 week study enrollment . Currently enrol professional tobacco cessation therapeutic intervention . Enrollment concurrent cancer therapeutic trial require prior review approval study site PI determine drug interaction concern .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Smoking</keyword>
	<keyword>Cessation</keyword>
	<keyword>Bupropion</keyword>
	<keyword>Varenicline</keyword>
	<keyword>Nicotine</keyword>
	<keyword>Counseling</keyword>
	<keyword>Tobacco</keyword>
</DOC>